1.51 AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall

<< vissza

AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall
Dátum: 2024-02-02 [news.yahoo.com]

A TELJES HÍR ELOLVASÁSA >>
×